A Review of DNA Methylation and microRNA Expression in Recurrent Pediatric Acute Leukemia

Victoria Hale, Gregory A. Hale, Patrick A Brown, Ernest Amankwah

Research output: Contribution to journalArticle

Abstract

Acute leukemia is the most common childhood cancer diagnosis and leading cause of cancer-related death among children and adolescents. Despite substantial improvements in the survival rate of childhood acute leukemia, approximately 20-40% of the patients who undergo treatment develop relapse, with a dismal one third of these patients surviving in the long term. Epigenetics plays an important role in the progression of cancer, and existing evidence suggests a role in childhood acute leukemia relapse. A better understanding of the epigenetic mechanisms in recurrent acute leukemia could potentially lead to novel therapeutic regimens to prevent or treat disease recurrences. In this review, we summarize existing evidence on two of the most studied epigenetic mechanisms, DNA methylation and microRNA expression, in recurrent pediatric acute leukemia.

Original languageEnglish (US)
JournalOncology
DOIs
StateAccepted/In press - Nov 2 2016

Fingerprint

DNA Methylation
MicroRNAs
Leukemia
Pediatrics
Epigenomics
Recurrence
Neoplasms
Survival Rate
Therapeutics

Keywords

  • Epigenetics
  • Methylation
  • microRNA
  • Pediatric leukemia
  • Recurrence

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

A Review of DNA Methylation and microRNA Expression in Recurrent Pediatric Acute Leukemia. / Hale, Victoria; Hale, Gregory A.; Brown, Patrick A; Amankwah, Ernest.

In: Oncology, 02.11.2016.

Research output: Contribution to journalArticle

@article{c46302725f294bc18be503fb8ba7397b,
title = "A Review of DNA Methylation and microRNA Expression in Recurrent Pediatric Acute Leukemia",
abstract = "Acute leukemia is the most common childhood cancer diagnosis and leading cause of cancer-related death among children and adolescents. Despite substantial improvements in the survival rate of childhood acute leukemia, approximately 20-40{\%} of the patients who undergo treatment develop relapse, with a dismal one third of these patients surviving in the long term. Epigenetics plays an important role in the progression of cancer, and existing evidence suggests a role in childhood acute leukemia relapse. A better understanding of the epigenetic mechanisms in recurrent acute leukemia could potentially lead to novel therapeutic regimens to prevent or treat disease recurrences. In this review, we summarize existing evidence on two of the most studied epigenetic mechanisms, DNA methylation and microRNA expression, in recurrent pediatric acute leukemia.",
keywords = "Epigenetics, Methylation, microRNA, Pediatric leukemia, Recurrence",
author = "Victoria Hale and Hale, {Gregory A.} and Brown, {Patrick A} and Ernest Amankwah",
year = "2016",
month = "11",
day = "2",
doi = "10.1159/000452091",
language = "English (US)",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",

}

TY - JOUR

T1 - A Review of DNA Methylation and microRNA Expression in Recurrent Pediatric Acute Leukemia

AU - Hale, Victoria

AU - Hale, Gregory A.

AU - Brown, Patrick A

AU - Amankwah, Ernest

PY - 2016/11/2

Y1 - 2016/11/2

N2 - Acute leukemia is the most common childhood cancer diagnosis and leading cause of cancer-related death among children and adolescents. Despite substantial improvements in the survival rate of childhood acute leukemia, approximately 20-40% of the patients who undergo treatment develop relapse, with a dismal one third of these patients surviving in the long term. Epigenetics plays an important role in the progression of cancer, and existing evidence suggests a role in childhood acute leukemia relapse. A better understanding of the epigenetic mechanisms in recurrent acute leukemia could potentially lead to novel therapeutic regimens to prevent or treat disease recurrences. In this review, we summarize existing evidence on two of the most studied epigenetic mechanisms, DNA methylation and microRNA expression, in recurrent pediatric acute leukemia.

AB - Acute leukemia is the most common childhood cancer diagnosis and leading cause of cancer-related death among children and adolescents. Despite substantial improvements in the survival rate of childhood acute leukemia, approximately 20-40% of the patients who undergo treatment develop relapse, with a dismal one third of these patients surviving in the long term. Epigenetics plays an important role in the progression of cancer, and existing evidence suggests a role in childhood acute leukemia relapse. A better understanding of the epigenetic mechanisms in recurrent acute leukemia could potentially lead to novel therapeutic regimens to prevent or treat disease recurrences. In this review, we summarize existing evidence on two of the most studied epigenetic mechanisms, DNA methylation and microRNA expression, in recurrent pediatric acute leukemia.

KW - Epigenetics

KW - Methylation

KW - microRNA

KW - Pediatric leukemia

KW - Recurrence

UR - http://www.scopus.com/inward/record.url?scp=84994091617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994091617&partnerID=8YFLogxK

U2 - 10.1159/000452091

DO - 10.1159/000452091

M3 - Article

C2 - 27802447

AN - SCOPUS:84994091617

JO - Oncology

JF - Oncology

SN - 0890-9091

ER -